nmpЖурнал им. Н.В. Склифосовского «Неотложная медицинская помощь»Russian Sklifosovsky Journal "Emergency Medical Care"2223-90222541-8017“N.V. Sklifosovsky Research Institute for Emergency Medicine”10.23934/2223-9022-2024-13-2-258-263nmp-1889Research ArticleОБЗОР ЛИТЕРАТУРЫREVIEWSCandida auris — новый возбудитель внутрибольничных инфекцийCandida auris — a New Pathogen of Nosocomial Infectionshttps://orcid.org/0000-0002-6167-7117ЧерненькаяТ. В.ChernenkayaT. V.

Татьяна Витальевна Черненькая, кандидат медицинских наук, заведующая лабораторией

Научная лаборатория клинической микробиологии

129090; Большая Сухаревская пл., д. 3; Москва

Tatyana V. Chernenkaya, Candidate of Medical Sciences, Head at the Laboratory

Scientific Laboratory of Clinical Microbiology

129090; Bolshaya Sukharevskaya Sq. 3; Moscow

chernenkayat@rambler.ruГБУЗ «Научно-исследовательский институт скорой помощи им. Н.В. Склифосовского ДЗМ»РоссияN.V. Sklifosovsky Research Institute for Emergency MedicineRussian Federation202404092024132258263Copyright © Черненькая Т.В., 20242024Черненькая Т.В.Chernenkaya T.V.This work is licensed under a Creative Commons Attribution 4.0 License.https://www.jnmp.ru/jour/article/view/1889

   В последние годы количество инфекционных заболеваний, вызываемых грибами, прогрессивно увеличивается и представляет серьезную клиническую проблему. Обзор литературы посвящен Candida auris — новому возбудителю нозокомиальных грибковых инфекций с множественной лекарственной устойчивостью. Этот возбудитель впервые описан в 2009 году. По состоянию на начало 2021 года документально подтвержденное выделение Candida auris отмечено в 47 странах мира. Этот возбудитель может длительно сохраняться на различных поверхностях в стационарах, устойчив к противогрибковым препаратам и традиционным дезинфектантам, вызывает инвазивные инфекции, сопровождающиеся высокой смертностью. Изучение Candida auris имеет важное значение как для разработки подходов к диагностике и лечению заболеваний, вызываемых этим возбудителем, так и для прогнозирования появления новых патогенов в будущем.

   In recent years, the number of infectious diseases caused by fungi has been progressively increasing, which is a serious clinical problem. The literature review is devoted to Candida auris — a new causative agent of nosocomial fungal infections with multidrug resistance. This pathogen was first described in 2009. As of the beginning of 2021, the documented isolation of Candida auris was noted in 47 countries around the world. This pathogen can persist for a long time on various surfaces in hospitals, is resistant to antifungal drugs and traditional disinfectants, and causes invasive infections accompanied by high mortality. The study of Candida auris is important both for the development of approaches to the diagnosis and treatment of diseases caused by this pathogen, and for predicting the emergence of new pathogens in the future.

Candida aurisгрибковая инфекциянозокомиальные инфекцииинфекционный контрольCandida aurisfungal infectionnosocomial infectionsinfection controlИсследование не имеет спонсорской поддержкиThe study had no sponsorshipReferencesSatoh K, Makimura K, Hasumi Y, Nishiyama Y, Uchida K, Yamaguchi H. Candida auris sp. nov., a novel ascomycetous yeast isolated from the external ear canal of an inpatient in a Japanese hospital. Microbiol Immunol. 2009;53(1):41–44. PMID: 19161556 doi: 10.1111/j.1348-0421.2008.00083.xSatoh K, Makimura K, Hasumi Y, Nishiyama Y, Uchida K, Yamaguchi H. Candida auris sp. nov., a novel ascomycetous yeast isolated from the external ear canal of an inpatient in a Japanese hospital. Microbiol Immunol. 2009;53(1):41–44. PMID: 19161556 doi: 10.1111/j.1348-0421.2008.00083.xLee WG, Shin JH, Uh Y, Kang MG, Kim SH, Park KH, et al. First Three Reported Cases of Nosocomial Fungemia Caused by Candida auris. J Clin Microbiol. 2011;49(9):3139–3142. PMID: 21715586 doi: 10.1128/JCM.00319-11Lee WG, Shin JH, Uh Y, Kang MG, Kim SH, Park KH, et al. First Three Reported Cases of Nosocomial Fungemia Caused by Candida auris. J Clin Microbiol. 2011;49(9):3139–3142. PMID: 21715586 doi: 10.1128/JCM.00319-11Chowdhary A, Sharma C, Duggal S, Agarwal K, Prakash A, Singh PK, et al. New clonal strain of Candida auris, Delhi, India. Emerg Infect Dis. 2013;19(10):1670–1673. PMID: 24048006 doi: 10.3201/eid1910.130393Chowdhary A, Sharma C, Duggal S, Agarwal K, Prakash A, Singh PK, et al. New clonal strain of Candida auris, Delhi, India. Emerg Infect Dis. 2013;19(10):1670–1673. PMID: 24048006 doi: 10.3201/eid1910.130393Govender NP, Magobo RE, Mpembe R, Mhlanga M, Matlapeng P, Corcoran C, et al. Candida auris in South Africa, 2012–2016. Emerg Infect Dis. 2018;24(11):2036–2040. PMID: 30334713 doi: 10.3201/eid2411.180368Govender NP, Magobo RE, Mpembe R, Mhlanga M, Matlapeng P, Corcoran C, et al. Candida auris in South Africa, 2012–2016. Emerg Infect Dis. 2018;24(11):2036–2040. PMID: 30334713 doi: 10.3201/eid2411.180368Borman AM, Szekely A, Johnson EM. Comparative Pathogenicity of United Kingdom Isolates of the Emerging Pathogen Candida auris and Other Key Pathogenic Candida Species. mSphere. 2016;1(4):e00189-16. PMID: 27547827 doi: 10.1128/mSphere.00189-16 eCollection 2016 Jul-Aug.Borman AM, Szekely A, Johnson EM. Comparative Pathogenicity of United Kingdom Isolates of the Emerging Pathogen Candida auris and Other Key Pathogenic Candida Species. mSphere. 2016;1(4):e00189-16. PMID: 27547827 doi: 10.1128/mSphere.00189-16 eCollection 2016 Jul-Aug.Schelenz S, Hagen F, Rhodes JL, Abdolrasouli A, Chowdhary A, Hall A, et al. First hospital outbreak of the globally emerging Candida auris in a European Hospital. Antimicrob Resist Infect Control. 2016;5:35 PMID: 27777756 doi: 10.1186/s13756-016-0132-5Schelenz S, Hagen F, Rhodes JL, Abdolrasouli A, Chowdhary A, Hall A, et al. First hospital outbreak of the globally emerging Candida auris in a European Hospital. Antimicrob Resist Infect Control. 2016;5:35 PMID: 27777756 doi: 10.1186/s13756-016-0132-5Hamprecht A, Barber AE, Mellinghoff SC, Thelen P, Walther G, Yu Y, et al. Candida auris in Germany and previous exposure to foreign healthcare. Emerg Infect Dis. 2019;25(9):1763–1765. PMID: 31223105 doi: 10.3201/eid2509.190262Hamprecht A, Barber AE, Mellinghoff SC, Thelen P, Walther G, Yu Y, et al. Candida auris in Germany and previous exposure to foreign healthcare. Emerg Infect Dis. 2019;25(9):1763–1765. PMID: 31223105 doi: 10.3201/eid2509.190262Vallabhaneni S, Kallen A, Tsay S, Chow N, Welsh R, Kerins J, et al. Investigation of the first seven reported cases of Candida auris, a globally emerging invasive, multidrug-resistant fungus – United States, May 2013-August 2016. MMWR Morb Mortal Wkly Rep. 2016;65(44):1234–1237. PMID: 27832049 doi: 10.15585/mmwr.mm6544e1Vallabhaneni S, Kallen A, Tsay S, Chow N, Welsh R, Kerins J, et al. Investigation of the first seven reported cases of Candida auris, a globally emerging invasive, multidrug-resistant fungus – United States, May 2013-August 2016. MMWR Morb Mortal Wkly Rep. 2016;65(44):1234–1237. PMID: 27832049 doi: 10.15585/mmwr.mm6544e1Barantsevich NE, Orlova OE, Shlyakhto EV, Johnson EM, Woodford N, Lass-Floerl C, et al. Emergence of Candida auris in Russia. J Hosp Infect. 2019;102(4):445–448. PMID: 30851375 doi: 10.1016/j.jhin.2019.02.021Barantsevich NE, Orlova OE, Shlyakhto EV, Johnson EM, Woodford N, Lass-Floerl C, et al. Emergence of Candida auris in Russia. J Hosp Infect. 2019;102(4):445–448. PMID: 30851375 doi: 10.1016/j.jhin.2019.02.021Plachouras D, Lötsch F, Kohlenberg A, Monnet DL; Candida auris survey collaborative group. Candida auris: epidemiological situation, laboratory capacity and preparedness in the European Union and European Economic Area, January 2018 to May 2019 separator. Euro Surveill. 2020;25(12):2000240. PMID: 32234118 doi: 10.2807/1560-7917.ES.2020.25.12.2000240Plachouras D, Lötsch F, Kohlenberg A, Monnet DL; Candida auris survey collaborative group. Candida auris: epidemiological situation, laboratory capacity and preparedness in the European Union and European Economic Area, January 2018 to May 2019 separator. Euro Surveill. 2020;25(12):2000240. PMID: 32234118 doi: 10.2807/1560-7917.ES.2020.25.12.2000240CDC Tracking Candida auris. Centers for Disease Control and Prevention; Atlanta, GA, USA. Available at: https://www.cdc.gov/candida-auris/tracking-c-auris/index.html [Accessed Oct 13, 2021].CDC Tracking Candida auris. Centers for Disease Control and Prevention; Atlanta, GA, USA. Available at: https://www.cdc.gov/candida-auris/tracking-c-auris/index.html [Accessed Oct 13, 2021].Chow NA, Munoz JF, Gade L, Berkow EL, Li X, Welsh RM, et al. Tracing the evolutionary history and global expansion of Candida auris using population genomic analyses. mBio. 2020;11(2):e03364-19. PMID: 32345637 doi: 10.1128/mBio.03364-19Chow NA, Munoz JF, Gade L, Berkow EL, Li X, Welsh RM, et al. Tracing the evolutionary history and global expansion of Candida auris using population genomic analyses. mBio. 2020;11(2):e03364-19. PMID: 32345637 doi: 10.1128/mBio.03364-19Lockhart SR, Etienne KA, Vallabhaneni S, Farooqi J, Chowdhary A, Govender NP, et al. Simultaneous Emergence of Multidrug-Resistant Candida auris on 3 Continents Confirmed by Whole-Genome Sequencing and Epidemiological Analyses. Clin Infect Dis. 2017;64(2):134–140. PMID: 27988485 doi: 10.1093/cid/ciw691Lockhart SR, Etienne KA, Vallabhaneni S, Farooqi J, Chowdhary A, Govender NP, et al. Simultaneous Emergence of Multidrug-Resistant Candida auris on 3 Continents Confirmed by Whole-Genome Sequencing and Epidemiological Analyses. Clin Infect Dis. 2017;64(2):134–140. PMID: 27988485 doi: 10.1093/cid/ciw691Сергеев А.Ю., Сергеев Ю.В. Кандидоз. Природа инфекции, механизмы агрессии и защиты, лабораторная диагностика, клиника и лечение. Москва: Триада-Х; 2001.Sergeev AYu, Sergeev YuV. Kandidoz. Priroda infektsii, mekhanizmy agressii i zashchity, laboratornaya diagnostika, klinika i lechenie. Moscow: Triada-Kh Publ.; 2001. (In Russ.)Навашин С.М., Фомина И.П. Рациональная антибиотикотерапия : справочник. Москва: Медицина; 1982.Navashin SM, Fomina IP. Ratsional’naya antibiotikoterapiya. Moscow: Meditsina Publ.; 1982. (In Russ.)Casadevall A, Kontoyiannis DP, Robert V. On the emergence of Candida auris: climate change, azoles, swamps, and birds. mBio. 2019;10(4). PMID: 31337723 doi: 10.1128/mBio.01397-19Casadevall A, Kontoyiannis DP, Robert V. On the emergence of Candida auris: climate change, azoles, swamps, and birds. mBio. 2019;10(4). PMID: 31337723 doi: 10.1128/mBio.01397-19Caceres DH, Forsberg K, Welsh RM, Sexton DJ, Lockhart SR, Jackson BR, et al. Candida auris: A Review of Recommendations for Detection and Control in Healthcare Settings. Review J Fungi (Basel). 2019;5(4):111. PMID: 31795175 doi: 10.3390/jof5040111Caceres DH, Forsberg K, Welsh RM, Sexton DJ, Lockhart SR, Jackson BR, et al. Candida auris: A Review of Recommendations for Detection and Control in Healthcare Settings. Review J Fungi (Basel). 2019;5(4):111. PMID: 31795175 doi: 10.3390/jof5040111Azar MM, Turbett SE, Fishman JA, Pierce VM. Donor-Derived Transmission of Candida auris During Lung Transplantation. Clin Infect Dis. 2017;65(6):1040–1042. PMID: 28520901 doi: 10.1093/cid/cix460Azar MM, Turbett SE, Fishman JA, Pierce VM. Donor-Derived Transmission of Candida auris During Lung Transplantation. Clin Infect Dis. 2017;65(6):1040–1042. PMID: 28520901 doi: 10.1093/cid/cix460Identification of Candida auris. Available at: https://www.cdc.gov/candida-auris/hcp/laboratories/identification-of-c-auris.html [Accessed Oct 13, 2021].Identification of Candida auris. Available at: https://www.cdc.gov/candida-auris/hcp/laboratories/identification-of-c-auris.html [Accessed Oct 13, 2021].Welsh RM, Bentz ML, Shams A, Houston H, Lyons A, Rose LJ, et al. Survival, persistence, and isolation of the emerging multidrug-resistant pathogenic yeast Candida auris on a plastic health care surface. J Clin Microbiol. 2017;55(10):2996–3005. PMID: 28747370 doi: 10.1128/JCM.00921-17Welsh RM, Bentz ML, Shams A, Houston H, Lyons A, Rose LJ, et al. Survival, persistence, and isolation of the emerging multidrug-resistant pathogenic yeast Candida auris on a plastic health care surface. J Clin Microbiol. 2017;55(10):2996–3005. PMID: 28747370 doi: 10.1128/JCM.00921-17Chaabane F, Graf A, Jequier L, Coste AT. Review on Antifungal Resistance Mechanisms in the Emerging Pathogen Candida auris. Front Microbiol. 2019;10:2788. PMID: 31849919 doi: 10.3389/fmicb.2019.02788 eCollection 2019.Chaabane F, Graf A, Jequier L, Coste AT. Review on Antifungal Resistance Mechanisms in the Emerging Pathogen Candida auris. Front Microbiol. 2019;10:2788. PMID: 31849919 doi: 10.3389/fmicb.2019.02788 eCollection 2019.Govender NP, Avenant T, Brink A, Chibabhai V, Cleghorn J, du Toit B, et al. Federation of Infectious Diseases Societies of Southern Africa guideline: Recommendations for the detection, management and prevention of healthcare-associated Candida auris colonisation and disease in South Africa. S Afr J Infect Dis. 2019;34(1):163. PMID: 34485460 doi: 10.4102/sajid.v34i1.163 eCollection 2019.Govender NP, Avenant T, Brink A, Chibabhai V, Cleghorn J, du Toit B, et al. Federation of Infectious Diseases Societies of Southern Africa guideline: Recommendations for the detection, management and prevention of healthcare-associated Candida auris colonisation and disease in South Africa. S Afr J Infect Dis. 2019;34(1):163. PMID: 34485460 doi: 10.4102/sajid.v34i1.163 eCollection 2019.Treatment and Management of Infections and Colonization. Recommendations for treatment of Candida auris infections. Available at: https://www.cdc.gov/candida-auris/hcp/clinical-care/index.html [Accessed Oct 13, 2021].Treatment and Management of Infections and Colonization. Recommendations for treatment of Candida auris infections. Available at: https://www.cdc.gov/candida-auris/hcp/clinical-care/index.html [Accessed Oct 13, 2021].Fakhim H, Chowdhary A, Prakash A, Vaezi A, Dannaoui E, Meis JF, et al. In vitro interactions of echinocandins with triazoles against multidrug-resistant Candida auris. Antimicrob Agents Chemother. 2017;61(11): e01056-17. PMID: 28848002 doi: 10.1128/AAC.01056-17Fakhim H, Chowdhary A, Prakash A, Vaezi A, Dannaoui E, Meis JF, et al. In vitro interactions of echinocandins with triazoles against multidrug-resistant Candida auris. Antimicrob Agents Chemother. 2017;61(11): e01056-17. PMID: 28848002 doi: 10.1128/AAC.01056-17Infection Prevention and Control for Candida auris. Available at: https://www.cdc.gov/candida-auris/hcp/infection-control/index.html [Accessed Oct 13, 2021].Infection Prevention and Control for Candida auris. Available at: https://www.cdc.gov/candida-auris/hcp/infection-control/index.html [Accessed Oct 13, 2021].Rapid risk assessment: Candida auris in healthcare settings – Europe. Available at: https://www.ecdc.europa.eu/en/publications-data/rapid-risk-assessment-candida-auris-healthcare-settings-europe [Accessed Oct 13, 2021].Rapid risk assessment: Candida auris in healthcare settings – Europe. Available at: https://www.ecdc.europa.eu/en/publications-data/rapid-risk-assessment-candida-auris-healthcare-settings-europe [Accessed Oct 13, 2021].Tsay S, Welsh RM, Adams EH, Chow NA, Gade L, Berkow EL, et al. Notes from the field: ongoing transmission of Candida auris in health care facilities – United States, June 2016-May 2017. MMWR Morb Mortal Wkly Rep. 2017;66(19):514–515. PMID: 28520710 doi: 10.15585/mmwr.mm6619a7Tsay S, Welsh RM, Adams EH, Chow NA, Gade L, Berkow EL, et al. Notes from the field: ongoing transmission of Candida auris in health care facilities – United States, June 2016-May 2017. MMWR Morb Mortal Wkly Rep. 2017;66(19):514–515. PMID: 28520710 doi: 10.15585/mmwr.mm6619a7Heath CH, Dyer JR, Pang S, Coombs GW, Gardam DJ. Candida auris Sternal Osteomyelitis in a Man from Kenya Visiting Australia, 2015. Emerg Infect Dis. 2019;25(1):192–194. PMID: 30561310 doi: 10.3201/eid2501.181321Heath CH, Dyer JR, Pang S, Coombs GW, Gardam DJ. Candida auris Sternal Osteomyelitis in a Man from Kenya Visiting Australia, 2015. Emerg Infect Dis. 2019;25(1):192–194. PMID: 30561310 doi: 10.3201/eid2501.181321

The authors declare that there are no conflicts of interest present.